Trial Details

Not Recruiting
Basic Information
Clinical ID c5661
Identifier NL-OMON51292
Trial Title A phase 1, randomized, double-blind, placebo-controlled, single ascending dose, multiple ascending dose and food effect study to evaluate the safety, tolerability, and pharmacokinetics of LMT503 in healthy subjects. - LMT503 First-in-human SAD, MAD, and F
Trial URL Visit Original Page
Study Information
Study Results

NULL
Conditions Inflammatory bowel disease long lasting inflammation of the digestive tract;10017969
Interventions In the table below shows the planned dose levels for each group. The doses after the first group can be adjusted based on the results of the previous group(s). For example because the study compound had more or less effect than was expected
Participant Information
Sponsor Lmito Therapeutics Inc.
City NULL
Country/Region Netherlands
Enrollment Criteria
Sex Requirement NOT SPECIFIED
Age Requirement ADULT
Study Design
Study Type Interventional
Phase NULL
Time Information
Start Date NULL
Primary Completion Date NULL
Completion Date NULL